October 15 - 18, 2019 | Sheraton Boston, MA

Cold Chain Expert Interviews

Digitization and Big Data's Impact

Digitization and Big Data's Impact

Pharma and biotech companies are implementing new technologies to enhance how they make decisions and predict outcomes in the supply chain.
End-to-End Supply Chain Visibility

End-to-End Supply Chain Visibility

The Associate Director of Supply Chain Management at Merck gives us deeper dive into end-to-end supply chain visibility in this white paper.
Moving Towards Collaboration Whitepaper

Moving Towards Collaboration Whitepaper

Collaboration has long been considered an effective approach and is employed by many highfunctioning organizations. In business and in communities, the strategic value of aligning yourself with other groups that have a shared vision, where each collaborator brings something to the table and is willing to work together to get there is now seen. Collaboration between different groups - within and outside the enterprise – makes for a changed dynamic. It is a commonly held view that stakeholders in collaboration are at their best, fully invested and engaged, even if conflict situations arise. This whitepaper dives into how collaboration is effective for the pharmaceutical supply chain industry.
Disruption in the Pharma Industry

Disruption in the Pharma Industry

What will technologies will disrupt the life sciences supply chain industry in 2018? To find out, we sat down with Paul Zikopoulos, VP of Competitive and Big Data Analytics Teams and Future Trends Expert, IBM, and the 2017 Global Forum's keynote speaker.

Future of Cold Chain: Blockchain’s Impact on Cold Chain Logistics

Future of Cold Chain: Blockchain’s Impact on Cold Chain Logistics

By 2020, pharma cold chain logistics spend is predicted to exceed $16 billion. Despite this huge investment, Pharmaceutical supply chains still face tremendous challenges. We sat down with keynote speaker Jack Shaw, Executive Director of the American Blockchain Council, Technology Futurist to discuss this.  Below is a preview of the interview:

What will be the Blockchain’s direct impact on the Pharmaceutical supply chain?

Pharmaceutical supply chains face tremendous challenges. Ingredients get lost, chemicals become inactive due to insufficient temperature control, medicines are wrongly prescribed by malfunctioning computer systems, and counterfeit medications slip through cracks in security.

All of these problems are causing pharma companies to turn to emerging technologies to improve visibility and control across the supply chain. Many companies have begun to realise the specific utility of blockchain technology in this endeavor.

The immutability of records, easy and transparent sharing of data among authorized ecosystem participants, and the virtually hack-proof capabilities of Blockchain (also known as Distributed Ledger Technology, or DLT) make it a powerful and effective choice for better managing supply chains of all kinds.

How will Blockchain technology affect cold chain logistics now and in the near future?

Blockchain offers an efficient way for wholesalers and dispensaries to optimize their inventory management and control, anticipate supply shortages, and improve data integrity as well as the distribution of data that has not previously existed.


Download the full report to get more insights on:

-Blockchain's direct impact on the Pharma Supply Chain
-Blockchain technology's affect on cold chain logistics
-Cold chain pharmaceuticals' preparation for the future of technology


If you would like a copy of the interview sent directly to you, please contact us here.




Healthcare Reform & the Future of the Pharma Supply Chain

Healthcare Reform & the Future of the Pharma Supply Chain

We sat down with David Merrit, Executive Vice President of Public Affairs and Strategy, America's Health Insurance Plans to discuss Healthcare Reform. Below is a preview of the interview:

How will healthcare reform affect the pharmaceutical supply chain?

"It seems you can’t talk health care today without talking about politics. How health reform will affect the supply chain depends on who’s in charge. The Trump Administration has put a very bright spotlight on rising prescription drug costs - from the very beginning of the process with manufacturers setting prices to the very end with what consumers pay at the pharmacy. Their focus has been on reducing regulation, increasing competition, and reducing what patients pay."

How does the national healthcare reform law affect the future of the pharma supply chain?

"Every American deserves access to affordable coverage and high-quality care. Policymakers and politicians will certainly debate how we balance affordability with access."


Download the Report to read the full conversation with David and hear what he has to say on:

  • Healthcare Reform's affect on the pharma supply chain
  • The national healthcare reform law affect on the future of the pharma supply Chain
  • His advise on healthcare reform to the presidential campaigns


If you would like a copy of the interview sent directly to you, please contact us here.




The ELD Mandate and Cold Chain

The ELD Mandate and Cold Chain

We sat down with one of our keynote speakers Bill Mahorney, Chief, Enforcement Division, FMCSA, Department of Transportation. As one of the key players responsible for enforcing the ELD Mandate, Bill will be addressing how this new law will affect the supply chain, logging books, hours of service regulations and cross-industry collaboration. To give you a sneak peek as to what you can expect to hear about onsite, we sat down with Bill to discuss what the ELD Mandate is and how it impacts the supply chain.

Below is a preview of the interview:

First and foremost, what is the ELD mandate?

"In a nutshell, the electronic logging device (ELD) rule [which was congressionally mandated as a part of MAP-21] is intended to help create a safer work environment for drivers as well as make it easier and faster to accurately track, manage, and share records of duty status (RODS) data. An ELD synchronizes with a vehicle engine to automatically record driving time, for easier, more accurate hours of service (HOS) recording. As a result of the ELD mandate, folks that used to use a logbook are now, as of December 2017, required to use an electronic logging device to ensure your hours of service are accurately recorded."

How does the ELD Mandate Affect the Cold Chain?

"We're talking about a device that is much more precise than an old fashioned logbook. Previously people could fudge here and there. Basically falsify and extend their day.

So, for example, if driver has to wait at a shipper location or got stuck because the shipper wasn't ready for them one way or the other, then they would not necessarily show that on their paper logbook. However, since an electronic logging device automatically records drive time and hours of service (HOS), in addition to being much more precise, it also cannot be manipulated by the driver or the carrier. 

For the most part, the ELD will change things in a good way when it comes to the supply chain. The precision of the ELDs is gong to require shippers the carriers to work more closely together to make sure that time is not wasted and that the supply chain is efficient as it can be. ELDs will enable drivers to more efficiently move in and out of the shipper's location either on the front end or the back end and maximize their hours of service while keeping the goods moving properly."

Download the full interview with Bill Mahorney below


If you would like a copy of the interview sent directly to you, please contact us here.



Serialization: Compliance risks to avoid

Serialization: Compliance risks to avoid

Serialization is set to revolutionize how business is done in pharma. It is a complex technical project involving engineering systems at line, distribution operation levels and enterprise IT systems, at site and global levels.

Coming back to today’s reality, and despite the years given for implementation, observers will be aware that a vast portion of the manufacturing landscape is behind schedule and is now scrambling to meet international compliance deadlines.

Download this whitepaper to discover:

  • Golden rules for serialization projects
  • The organizational and technical challenges that creep into serialization projects
  • The dangers of leaving implementation too late
  • How serialization powers pharma's digital transformation
The Autonomous Supply Chain is Coming

The Autonomous Supply Chain is Coming

Ahead of the 16th Global Forum taking place September 24-28, 2018 in Philadelphia, PA, we sat down with keynote speaker Tom Bonkenburg, Director, European Operations, St. Onge Company.  Below is a preview of the interview:

How is Robotics impacting the supply chain sector?

"Since their beginning, robots have always lived in the ‘make’ side of the supply chain. Robots are very good at precisely repeating the same tasks hour after hour with high quality. This is a good fit for manufacturing where exacting precision is often an important requirement and robots are used to improve quality while reducing the cost of labor.

"The challenges typically found in the ‘deliver’ side, however, often require flexibility rather than exacting precision and the traditional manufacturing robots have not been a good fit. We now see new robotic concepts being developed that are about to enter the distribution arena allowing organizations to improve quality and reduce labor in the customer facing half of the supply chain. I find this an exciting development that will change the way we design our supply chains of the future."

What are the top two challenges companies face when it comes to adopting these new automated technologies?

"One of the main challenges that I see companies facing is their outlook on capital spending and ROI. Many corporations require a payback of 3 years or less for new projects and this often makes it difficult to implement automated technologies. I see this changing, however, as businesses are having trouble finding quality labor and now view automation as a longer term strategic investment. In addition to this shift in thinking, newer technologies coming onto the market will be more flexible in their finance models allowing operations to lease rather than buy robots or move them from site to site as needed to help keep capital spending lower than it has been in the past.

 A second challenge is that what works well in one industry does not always work in another. Every supply chain and every distribution center is different. Just because a technology works for Amazon does not mean it will work for you. Very often the CSuite does not understand this and tries to push in a technology direction that is not a good fit for them. Really understanding how the needs of your particular supply chain maps against available technology is key to making a good decision and getting buy in from the entire organization."

How do you see robotics transforming the pharma supply chain industry over the next 10-15 years? 

I try to never predict what will happen by a specific date in time because we have been disappointed by technology projections in the past. In my opinion, however, the current trends will eventually lead to automation allowing smaller DCs to be productive throughout the day and night, faster service to customers, lower inventory levels, and an overall reduction in cost. Automation will continue to shape the supply chain and changes seem to come faster and faster every year.


Download the full Report to read the full discussion with Tom as he discusses:

  • How robotics are impacting the the pharma supply chain sector specifically
  • Common barriers to automation adoption and how to overcome them
  • What life sciences supply chain leaders need to do today to prepare for a future of increased automation


If you would like a copy of the interview sent directly to you, please contact us here.